Published in Support Care Cancer on March 29, 2016
Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res (2006) 7.83
Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol (2012) 3.65
Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. J Clin Oncol (2011) 3.05
Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients. J Pain Symptom Manage (2010) 1.39
A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol (2006) 1.38
The measurement of pain from metastatic bone disease: capturing the patient's experience. Clin Cancer Res (2006) 1.35
Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration. Br J Cancer (2005) 1.30
The Cancer Care Monitor: psychometric content evaluation and pilot testing of a computer administered system for symptom screening and quality of life in adult cancer patients. J Pain Symptom Manage (2003) 1.16
Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study. Support Care Cancer (2014) 1.14
Prevalence, intensity, and predictors of the supportive care needs of women diagnosed with breast cancer: a systematic review. Psychooncology (2013) 1.14
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer (2013) 1.12
Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer. Pain (2004) 1.08
Use of electronic medical records (EMR) for oncology outcomes research: assessing the comparability of EMR information to patient registry and health claims data. Clin Epidemiol (2011) 1.07
Validation of the Cancer Care Monitor items for physical symptoms and treatment side effects using expert oncology nurse evaluation. J Pain Symptom Manage (2006) 1.04
Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer (2012) 0.99
Quality of life and experience of care in women with metastatic breast cancer: a cross-sectional survey. J Pain Symptom Manage (2011) 0.98
The association of physical and psychological symptom burden with time to death among palliative cancer outpatients. J Pain Symptom Manage (2008) 0.97
Prospective longitudinal evaluation of a symptom cluster in breast cancer. J Pain Symptom Manage (2013) 0.88
Cancer-related fatigue and associated disability in post-treatment cancer survivors. J Cancer Surviv (2015) 0.85
Estimating minimally important differences for the worst pain rating of the Brief Pain Inventory-Short Form. J Support Oncol (2011) 0.85
Quality of life after local external beam radiation therapy for symptomatic bone metastases: a prospective evaluation. Support Cancer Ther (2004) 0.82
Patients as educators: interprofessional learning for patient-centred care. Med Teach (2013) 0.82
Trajectories of Depressive Symptoms Following Breast Cancer Diagnosis. Cancer Epidemiol Biomarkers Prev (2015) 0.81
Changes in and predictors of severity of fatigue in women with breast cancer: A longitudinal study. Int J Nurs Stud (2013) 0.81
Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patients. Health Qual Life Outcomes (2011) 0.80
Evolution of cancer-related symptoms over an 18-month period. J Pain Symptom Manage (2012) 0.80
Symptom burden clusters: a challenge for targeted symptom management. A longitudinal study examining symptom burden clusters in breast cancer. J Pain Symptom Manage (2013) 0.80
Relationship between incidence of fracture and health-related quality-of-life in metastatic breast cancer patients with bone metastases. J Med Econ (2012) 0.80
Effect of oral bisphosphonates for osteoporosis on development of skeletal metastases in women with breast cancer: results from a pharmaco-epidemiological study. J Natl Cancer Inst (2014) 0.80
Depressive episodes, symptoms, and trajectories in women recently diagnosed with breast cancer. Breast Cancer Res Treat (2015) 0.78
The role of palliative external beam radiation therapy in boney metastases pain management. J Pain Palliat Care Pharmacother (2013) 0.78
The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group. Clin Breast Cancer (2013) 0.77
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer. Support Care Cancer (2015) 0.99
Health resource utilization associated with skeletal-related events: results from a retrospective European study. Eur J Health Econ (2015) 0.80
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease. Eur J Cancer (2015) 0.79
Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States. Clin Epidemiol (2015) 0.78
Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer. Support Care Cancer (2015) 0.76
Utilization of agents to prevent skeletal-related events among patients with multiple myeloma: analysis of real-world data. Support Care Cancer (2017) 0.75